CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer

Definitive chemoradiotherapy (CRT) is a less invasive therapy compared with surgery for some types of cancer; however, the 5‑year survival rate of patients with stages II‑III esophageal squamous cell carcinoma (ESCC) is only 37%. Therefore, prediction of CRT responders is necessary. Unfortunately, n...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of oncology 2020-03, Vol.56 (3), p.835-847
Hauptverfasser:	Takashima, Kenji, Fujii, Satoshi, Komatsuzaki, Rie, Komatsu, Masayuki, Takahashi, Mari, Kojima, Takashi, Daiko, Hiroyuki, Minashi, Keiko, Chiwaki, Fumiko, Muto, Manabu, Sasaki, Hiroki, Yano, Tomonori
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antigens Biological markers Biomarkers Breast cancer Cancer therapies Carcinoma Cervical cancer Chemotherapy Deoxyribonucleic acid DNA Esophageal cancer Gastric cancer Gene expression Health aspects Immunohistochemistry Instrument industry (Equipment) Keratin Medical prognosis Messenger RNA Metastasis Ovarian cancer Prognosis Radiation therapy RNA Scientific equipment industry Squamous cell carcinoma Superoxides Surgery Transcription factors Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!